aCD47 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

61 results for “aCD47”

Trials

View all 17 →

CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies

20 participants · First posted Feb 9, 2016

Clinical Efficacy and Safety of CD47 Monoclonal Antibody Combined With Azacitidine in the Treatment of Recurrent AML After Transplantation

69 participants · First posted Mar 4, 2022

Active, not recruiting

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

47 participants · First posted Aug 27, 2021

Drugs

View all 32 →

YB1-CD47

LLO-CD47

CD47 x ABCG2

News

View all 12 →

Hydrogel Implant Eliminates Brain Cancer Recurrence in Mice

CD47-Targeted Immunotherapies Show Promise in Cancer Treatment

CD47 Expression Predicts Response to Magrolimab Plus Docetaxel in Metastatic NSCLC

Page 1 of 7